Pan-cancer multi-omic integration of Trop2 reveals biological determinants and translational implications for ADC therapy. [PDF]
Notini G +21 more
europepmc +1 more source
Cost-effectiveness of datopotamab deruxtecan in previously treated advanced nonsquamous NSCLC. [PDF]
Song Y.
europepmc +1 more source
Antibody-drug conjugates in breast cancer: mechanisms of resistance and future therapeutic perspectives. [PDF]
Valle I +3 more
europepmc +1 more source
Immune checkpoint inhibitors in resectable non-small cell lung cancer: recent successes and ongoing challenges. [PDF]
Abodunrin FO +4 more
europepmc +1 more source
Preclinical Activity of Datopotamab Deruxtecan, an Antibody-Drug Conjugate Targeting Trophoblast Cell-Surface Antigen 2, in Uterine Serous Carcinoma. [PDF]
Greenman M +11 more
europepmc +1 more source
[Anales del Sistema Sanitario de Navarra in 2025: Progress continues]. [PDF]
Godoy P, Beorlegui C.
europepmc +1 more source
Therapeutic Potential of Datopotamab Deruxtecan in the Treatment of Advanced Non-Small Cell Lung Cancer: Evidence to Date. [PDF]
Gogtay M +3 more
europepmc +1 more source
Clinical application and optimization strategies for antibody-drug conjugates in solid tumors. [PDF]
Qu J +7 more
europepmc +1 more source
[Ultrasound diagnosis of nephrocalcinosis in an infant with recurrent vomiting]. [PDF]
Carrasco Hidalgo-Barquero MC +2 more
europepmc +1 more source

